U.S. Marine and Shipping Stock News

MBX Biosciences (MBX) has reached a key clinical milestone with the first patient now dosed in its pivotal global Phase 3 oPTimize trial of once-weekly canvuparatide for chronic hypoparathyroidism. This step anchors current investor attention. For context, MBX Biosciences shares now trade at US$66.39, with a 30-day share price return of 10.54% and a 90-day share price return of 110.96%. The 1-year total shareholder return of 365.24% points to strong momentum as this Phase 3 trial gets...

With Canada preparing 15% to 50% retaliatory tariffs on U.S. goods and Arizona’s US$676 million export link to Canadian buyers under pressure, the fresh produce trade now sits at the crossroads of politics and profit. For investors, that creates potential mispricing as the market weighs tariff risk against long term demand for foodservice and distribution. This article walks through 3 stocks exposed to this news and explains why they may warrant closer attention before Sept. 8. The stocks...

On 24 August 2026, Tempus AI received FDA 510(k) clearance for Tempus ECG-PH, an AI tool that analyzes standard 12-lead ECGs for signs associated with pulmonary hypertension in symptomatic patients over 40 without a known history of the disease. This third FDA-cleared cardiovascular device extends Tempus AI’s AI-enabled diagnostics portfolio into pulmonary hypertension, a hard-to-diagnose condition affecting a meaningful share of older adults. We’ll now examine how this new FDA-cleared...

NPK International (NPKI) recently completed its rebranding from Newpark Resources Inc. The stock now reflects a clearer focus on temporary worksite access solutions that span power transmission, energy, and broader infrastructure services. NPK International’s share price has seen mixed momentum in recent months, with a 1-day share price return of 2.81% and a 30-day share price return of 4.71%, while the 90-day share price return is down 6.68%. At the same time, the stock’s longer history...

The Morning Bull - US Market Morning Update Friday, Aug, 28 2026 US Market stock futures are pointing higher this morning, with E-mini S&P 500 contracts up about 0.5% and Nasdaq-100 futures gaining more than 1%. The move comes after US durable goods orders rose 1.1% in July, which suggests companies are still spending on big ticket items like planes and machinery. At the same time, the PCE price index, a key inflation gauge watched by the Federal Reserve, increased 0.2% in July and is running...

Innodata has delivered very strong share price gains over the past five years, yet current valuation checks point to a stock that screens as expensive rather than a clear bargain. After such a long run, investors now have to weigh those historic returns against what the current price implies for the next leg of the story. Innodata has returned about 6.3x over 5 years, which puts extra focus on whether the current price already embeds very optimistic expectations. Recent leadership changes...

Alcoa Corporation recently held a groundbreaking ceremony for a new gallium production plant at its Wagerup alumina refinery in Western Australia, a project backed by government and industry partners from Australia, Japan and the United States and expected to support both construction and ongoing local jobs. The project’s focus on gallium, a critical mineral used in high-tech applications, underlines Alcoa’s expanding role in critical mineral supply chains alongside its core aluminum...

How Old National Bancorp Stock Has Been Trading Old National Bancorp (ONB) has drawn attention after a mixed stretch of recent returns. The stock is up slightly over the past week, roughly flat over the month, and higher over the past 3 months and year to date. At a share price of US$25.85, Old National Bancorp has delivered a 14.63% year to date share price return. Its 1 year total shareholder return of 16.35% and 3 year total shareholder return of 83.05% point to momentum that has built...

Earlier this week, UBS upgraded Fluence Energy’s stock rating from Sell to Neutral, signaling a shift in analyst stance despite the company’s continued loss-making and cash-burning profile. This change in sentiment stands out because it comes even as Fluence Energy’s negative EPS and constrained access to capital remain key concerns for cautious investors. We’ll now examine how UBS’s shift to a Neutral rating influences Fluence Energy’s investment narrative, particularly around risk...

Rockwell Automation recently launched TechConnectIQ Support, a 24x7 remote support offering for North American single-site contract customers, featuring AI-enabled tools, three-tier coverage, and improved visibility through the myRockwellAutomation TechConnect hub. The move highlights how Rockwell is aiming to deepen customer relationships by shifting more of its automation expertise into always-available, digitally delivered services. Next, we’ll explore how this enhanced remote support and...

Manhattan Associates (MANH) has drawn fresh attention after reporting better than expected second quarter 2026 earnings and revenue, and raising full year guidance for total and cloud revenue, which gives investors new information to assess the stock. The recent earnings surprise sits alongside strong share price momentum for Manhattan Associates, with a 90 day share price return of 49.12% and a 30 day share price return of 33.06%, while the 1 year total shareholder return of 2.43% shows much...

Morningstar and its subsidiary PitchBook previously announced upcoming Model Context Protocol integrations with Google Cloud’s Gemini Enterprise for Financial Services, bringing their public and private market intelligence directly into Gemini’s AI-powered workflows for eligible institutional users. The move effectively embeds Morningstar and PitchBook as core, source-attributed data and research providers inside Gemini Enterprise, potentially reshaping how professionals conduct investment...

Sarepta Therapeutics (SRPT) is back in focus after investors reacted to expectations for late 2026 clinical data in facioscapulohumeral muscular dystrophy and myotonic dystrophy, alongside developments in its Duchenne therapy Elevidys and a competitor setback. Sarepta Therapeutics' recent 1 day share price return of 10.95% and 30 day share price return of 39.92% suggest momentum has picked up as traders react to the Elevidys update and reduced competition. However, the 3 year total...

Moog (MOG.A) is in focus after opening its Advanced Integrated Manufacturing facility in Western New York. The $150 million project coincides with upward revisions to the company’s near term earnings estimates. Against this backdrop, Moog’s share price has been volatile in the short term, with a 30 day share price return down 7.6%. At the same time, the year to date share price return is 53.4%, and the 5 year total shareholder return is 404.6%. This pattern suggests that momentum has been...

AT&T (T) is in focus after Hark announced a partnership that pairs AT&T’s network infrastructure with Hark’s AI-native consumer devices, connecting hardware directly to AI without relying on phones or Wi-Fi. Against this backdrop, AT&T’s 30 day share price return of 3.12% and 90 day share price return of 2.54% suggest modest positive momentum, while the 3 year total shareholder return of 101.35% sits in sharp contrast to the 1 year total shareholder return, which declined 7.99%. This...

Earlier this week, Zacks highlighted Horace Mann Educators Corporation (HMN) as a top value and income stock, citing its Rank #1 (Strong Buy) rating, 6.2% rise in current-year earnings estimates over the past 60 days, and a price-to-earnings ratio below the broader insurance industry. HMN’s inclusion on both Zacks’ value and income stock lists, supported by a dividend yield above the industry average, underscores growing analyst confidence in the company’s earnings and income profile. Next,...

AI, smarter cars, and fresh government support have turned the semiconductor story into one of the most closely watched areas on the market, with chipmakers racing to add capacity and upgrade tools. That creates potential openings for investors who act before sentiment fully adjusts to these shifts. This article explores how recent news ties into three stocks from a global semiconductor and equipment screener that could be worth a closer look. The three stocks below are just a starting sample...

Why Western Alliance Bancorporation stock moved after Q2 earnings Western Alliance Bancorporation (WAL) recently reported Q2 results with revenue in line with analyst expectations but a clear miss on EPS estimates, which triggered concerns about profitability among investors. The stock has fallen 1.2% since the report, reflecting this shift in sentiment rather than any surprise on the top line. For you as a shareholder or potential investor, the key question is how that earnings shortfall...

Backlash over controversial ad puts Callaway Golf (CALY) under scrutiny Callaway Golf (CALY) is under pressure after a controversial advertisement showed a male golfer shoving a woman to the ground. CEO Chip Brewer has apologized and acknowledged the damage to the brand. The backlash has extended beyond social media. Some business partners are reconsidering ties with Callaway Golf, with reports of sponsorships and merchandise being pulled as stakeholders reassess the reputational risk. The...

Forestar Group stock overview Forestar Group (FOR) is drawing investor attention as a US residential lot developer with US$1.7b in revenue and US$170.4m in net income. The company operates as a subsidiary of D.R. Horton. Forestar Group’s share price has eased recently, with a 1-month share price return of 2.45% and a 7-day share price return of 0.90% lower. Yet the year-to-date share price return of 17.68% and 90-day gain of 4.19% suggest momentum has been building over a longer stretch,...

Textron earnings and portfolio shift draw fresh attention to the stock Textron (TXT) has moved into focus after reporting second quarter 2026 adjusted earnings of US$1.62 per share, alongside year over year revenue growth and a planned sale of its Industrial segment. For investors, this combination of an earnings beat and a potential reshaping of the business raises fresh questions about where Textron stock might fit in a diversified portfolio over the coming year. Over the past few months...

Universal (UVV) has drawn investor attention after recent share price moves, with the stock down about 16% over the past month and around 11% over the past 3 months based on provided returns. Over the past year, Universal’s share price has eased, reflected in a year to date share price return of down 12.59%, while the 1 year total shareholder return of down 11.51% pairs this weaker recent momentum with more resilient 3 and 5 year total shareholder returns of 16.34% and 23.05%. Spot...

Visa (V) has rolled out fresh cybersecurity upgrades around its open source Visa Vulnerability Agentic Harness framework, giving investors another data point on how the company applies AI to risk management within its broader payments business. The stock has eased 1.1% on a 1 day share price return basis to US$379.66; however, that comes after a 16.3% 90 day share price return and a 9.6% year to date share price return, while total shareholder return over 5 years sits at 75.9%. This suggests...

RTX (RTX) is back in focus after winning a multi year US military contract to ramp up Tomahawk missile production, securing work on the B 52 modernization effort, and expanding a key electronic warfare facility. For investors watching RTX, the recent Tomahawk contract win, B 52 work and electronic warfare expansion come against a share price of $212.08 and a mixed near term picture, with the 30 day share price return down 2.97% but the 90 day share price return up 18.05% and longer term total...